Condition present | Condition absent | P value | |
---|---|---|---|
Klotho | |||
Central obesity (N = 116) | 156.4 (89.6 to 350.9) | 118.5 (48.4 to 177.5) | 0.0275 |
Low HDL (N = 32) | 156.4 (92.4 to 266.7) | 134.4 (75.5 to 335.8) | 0.8202 |
High TG (N = 23) | 134.2 (90.7 to 321.1) | 140.3 (75.5 to 313.0) | 0.5620 |
Hypertension (N = 63) | 157.5 (90.2 to 321.1) | 136.0 (63.9 to 313.0) | 0.1975 |
Metabolic syndrome (N = 18) | 172.7 (123.0 to 321.1) | 135.0 (75.1 to 305.0) | 0.2050 |
Impaired glucose tolerance (N = 8) | 159.6 (131.8 to 208.3) | 136.4 (75.5 to 323.1) | 0.4948 |
Insulin resistance (N = 48) | 185.3 (102.1 to 398.2) | 132.6 (63.9 to 275.6) | 0.0283 |
FGF19 | |||
Central obesity (N = 116) | 160.6 (92.2 to 260.2) | 229.4 (119.5 to 345.0) | 0.0264 |
Low HDL (N = 32) | 147.6 (79.4 to 257.8) | 194.2 (112.4 to 289.2) | 0.1727 |
High TG (N = 23) | 124.3 (79.3 to 213.8) | 184.9 (112.4 to 297.8) | 0.0136 |
Hypertension (N = 63) | 145.7 (93.3 to 244.5) | 197.7 (101.1 to 299.7) | 0.1085 |
Metabolic syndrome (N = 18) | 133.0 (62.2 to 171.2) | 186.5 (109.2 to 284.7) | 0.0509 |
Impaired glucose tolerance (N = 8) | 86.9 (65.4 to 149.4) | 183.8 (106.0 to 289.2) | 0.0416 |
Insulin resistance (N = 48) | 143.0 (81.5 to 229.3) | 195.6 (118.2 to 297.8) | 0.0233 |
FGF21 | |||
Central obesity (N = 116) | 93.0 (48.8 to 199.5) | 70.1 (31.5 to 108.6) | 0.0193 |
Low HDL (N = 32) | 100.3 (48.8 to 165.1) | 84.7 (42.1 to 161.0) | 0.5064 |
High TG (N = 23) | 124.6 (78.6 to 363.5) | 81.1 (39.5 to 151.3) | 0.0035 |
Hypertension (N = 63) | 124.6 (61.3 to 260.3) | 75.2 (39.4 to 115.3) | 0.0004 |
Metabolic syndrome (N = 18) | 136.2 (86.5 to 239.9) | 82.6 (41.8 to 152.4) | 0.0286 |
Impaired glucose tolerance (N = 8) | 107.2 (66.2 to 216.8) | 86.4 (42.2 to 161.0) | 0.4767 |
Insulin resistance (N = 48) | 91.9 (44.5 to 159.0) | 82.6 (42.2 to 161.0) | 0.6314 |